 |
市場調查報告書
商品編碼
1449285
他克莫司市場、佔有率、市場規模、趨勢、行業分析報告：按產品類型、最終用途、按地區、按細分市場、預測，2024-203Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 203 |
||||||
價格
根據Polaris Market Research的最新研究，預計到2032年他克莫司市場規模將達到96.8326億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。
器官移植率的提高正在推動他克莫司市場的成長。 他克莫司是一種強效免疫抑制劑，廣泛用於移植患者，以防止新移植器官的排斥反應。 他克莫司市場的持續醫學研究和藥物進展為改善移植後患者的預後做出了重大貢獻。 這些進展不僅提高了他克莫司的療效，而且還導致了更具針對性和個性化的免疫抑制方法的發展。 他克莫司（一種用於預防移植後器官排斥的藥物）的可用性和可及性的增加提高了器官移植率。 移植程序的簡化和器官捐贈的宣傳活動也促進了他克莫司市場的成長。
器官移植技術的進步正在推動他克莫司市場的成長。 微創移植技術的進步、器官保存方法的改進以及移植成功率的提高增加了對免疫抑制劑的需求。 他克莫司已成為移植醫學中的重要藥物，因為它比傳統藥物更有效且副作用更少。 隨著手術技術和移植後護理的進步，他克莫司等免疫抑製藥物的使用增加。 由於移植手術數量的增加以及移植作為治療多種疾病的有效方法被廣泛接受，對他克莫司的需求正在增加。
隨著人口老化的加劇，對他克莫司等藥物的需求也預計會增加。 這是因為老年人經常需要器官移植或面臨免疫相關疾病。 醫療保健系統正在適應老齡化人口不斷變化的醫療保健需求，為他克莫司製造商和供應商創造了巨大的市場機會。
他克莫司市場報告亮點
片劑和膠囊在 2023 年佔最大的市場佔有率，因為他克莫司更容易讓患者服用並提高依從性。
由於器官移植手術數量的增加，免疫抑制劑將在2023年佔市場主導地位。
由於器官移植的迅速增加以及該地區主要參與者的存在，北美在他克莫司市場上佔主導地位。
目錄
第1章簡介
第 2 章執行摘要
第3章研究方法
第4章全球他克莫司市場洞察
- 他克莫司市場 - 最終用途快照
- 他克莫司市場動態
- 推動者和機會
- 研發活動的增加推動他克莫司市場成長
- 自體免疫疾病盛行率的增加推動市場成長
- 抑制因素和挑戰
- 不良反應和替代療法的可用性阻礙了他克莫司市場的成長
- 推動者和機會
- PESTEL 分析
- 他克莫司市場最終用途趨勢
- 價值鏈分析
- COVID-19 感染的影響分析
第 5 章全球他克莫司市場（依產品類型）
- 主要發現
- 簡介
- 注射
- 片劑和膠囊
- 其他
第 6 章全球他克莫司市場（按應用）
- 主要發現
- 簡介
- 皮膚炎
- 免疫抑制
- 其他
第 7 章全球他克莫司市場，依最終用途劃分
- 主要發現
- 簡介
- 診所
- 醫院
- 其他
第 8 章按地區劃分的全球他克莫司市場
- 主要發現
- 簡介
- 2019-2032 年他克莫司市場評估（按地區）
- 他克莫司市場 - 北美
- 北美：他克莫司市場，依產品類型，2019-2032 年
- 北美：他克莫司市場，依最終用途，2019-2032 年
- 北美：他克莫司市場，按應用劃分，2019-2032 年
- 他克莫司市場 - 美國
- 他克莫司市場 - 加拿大
- 他克莫司市場 - 歐洲
- 歐洲：他克莫司市場，依產品類型，2019-2032 年
- 歐洲：他克莫司市場，依最終用途，2019-2032 年
- 歐洲：他克莫司市場，按應用劃分，2019-2032 年
- 他克莫司市場 - 英國
- 他克莫司市場 - 法國
- 他克莫司市場 - 德國
- 他克莫司市場 - 義大利
- 他克莫司市場 - 西班牙
- 他克莫司市場 - 荷蘭
- 他克莫司市場 - 俄羅斯
- 他克莫司市場 - 亞太地區
- 亞太地區：他克莫司市場，依產品類型，2019-2032 年
- 亞太地區：他克莫司市場，依最終用途，2019-2032 年
- 亞太地區：他克莫司市場，依應用劃分，2019-2032 年
- 他克莫司市場 - 中國
- 他克莫司市場 - 印度
- 他克莫司市場 - 馬來西亞
- 他克莫司市場 - 日本
- 他克莫司市場 - 印度尼西亞
- 他克莫司市場－韓國
- 他克莫司市場 - 中東和非洲
- 中東和非洲：他克莫司市場，依產品類型，2019-2032 年
- 中東和非洲：他克莫司市場，依最終用途分類，2019-2032 年
- 中東和非洲：他克莫司市場，按應用劃分，2019-2032 年
- 他克莫司市場 - 沙烏地阿拉伯
- 他克莫司市場 - 阿拉伯聯合大公國
- 他克莫司市場 - 以色列
- 他克莫司市場 - 南非
- 他克莫司市場 - 拉丁美洲
- 拉丁美洲：他克莫司市場，依產品類型，2019-2032 年
- 拉丁美洲：他克莫司市場，依最終用途，2019-2032 年
- 拉丁美洲：他克莫司市場，按應用劃分，2019-2032 年
- 他克莫司市場 - 墨西哥
- 他克莫司市場 - 巴西
- 他克莫司市場 - 阿根廷
第9章競爭態勢
- 擴張與收購分析
- 放大
- 收購
- 夥伴關係/協作/協議/揭露
第10章公司簡介
- Astellas Pharma Inc
- Biocon Ltd.
- Dr. Reddy's Laboratories Ltd.
- Glenmark Pharmaceuticals Inc
- GlaxoSmithKline plc
- LEO Pharma A/S
- Novartis AG
- Lupin Pharmaceuticals Inc.
- Panacea Biotec
- Pfizer Inc
Product Code: PM4519
The tacrolimus market size is expected to reach USD 9,683.26 million by 2032, according to a new study by Polaris Market Research. The report "Tacrolimus Market Share, Size, Trends, Industry Analysis Report, By Product Type (Injections, Tablets and Capsules, Others); By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing organ transplantation rates drive the tacrolimus market growth. Tacrolimus is a potent immunosuppressive drug extensively used in transplant patients to prevent the rejection of newly transplanted organs. The continuous advancements in medical research and pharmaceuticals within the tacrolimus market have significantly contributed to improving patient outcomes post-transplantation. These developments have not only enhanced the efficacy of tacrolimus but have also led to the development of more targeted and personalized approaches to immunosuppression. The increasing availability and accessibility of tacrolimus, a medication used to prevent organ rejection after transplantation, has led to a favorable increase in organ transplantation rates. Efforts to simplify transplantation procedures and educate the public on organ donation have also contributed to the tacrolimus market growth.
The advancements in organ transplantation procedures foster the tacrolimus market growth. The need for immunosuppressants has been on the rise due to advancements in minimally invasive transplant procedures, improved organ preservation methods, and higher success rates of transplants. Tacrolimus has emerged as a crucial medication in transplantation medicine because of its effectiveness and fewer side effects in comparison to traditional drugs. With advancements in surgical techniques and post-transplant care, the use of immunosuppressive drugs such as tacrolimus has increased. The demand for tacrolimus has increased due to the growing number of transplant surgeries and the wider acceptance of transplantation as an effective treatment for various medical conditions.
As the geriatric population grows, the demand for medications like tacrolimus is expected to increase. This is because older adults often require organ transplants or face immune-related disorders. Healthcare systems are adapting to meet the evolving healthcare needs of this aging demographic, creating a significant market opportunity for tacrolimus manufacturers and suppliers.
Tacrolimus Market Report Highlights
The tablets and capsules segment held the largest market share in 2023 due to tacrolimus being favorable and easy for patients to consume, ensuring better compliance with medication regimens.
The immunosuppression segment dominated the market in 2023 due to the rising number of organ transplant surgeries.
North America dominated the tacrolimus market, owing to the surge in organ transplants and the presence of the key players in the region.
The key market players include Astellas Pharma Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Inc., GlaxoSmithKline plc, LEO Pharma A/S, Novartis AG, Lupin Pharmaceuticals Inc., Panacea Biotec, and Pfizer Inc.
Polaris Market Research has segmented the tacrolimus market report based on product, application, end-use, and region:
Polypropylene Nonwoven Fabrics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)
- Injections
- Tablets and Capsules
- Others
Polypropylene Nonwoven Fabrics, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Dermatitis
- Immunosuppression
- Others
Polypropylene Nonwoven Fabrics, End-Use Outlook (Revenue - USD Million, 2019 - 2032)
- Clinics
- Hospitals
- Others
Polypropylene Nonwoven Fabrics, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Australia
- Malaysia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Table of Contents
1.Introduction
- 1.1.Report Description
- 1.1.1.Objectives of the Study
- 1.1.2.Market Scope
- 1.1.3.Assumptions
- 1.2.Stakeholders
2.Executive Summary
- 2.1.Market Highlights
3.Research Methodology
- 3.1.Overview
- 3.1.1.Data Mining
- 3.2.Data Sources
- 3.2.1.Primary Sources
- 3.2.2.Secondary Sources
4.Global Tacrolimus Market Insights
- 4.1.Tacrolimus Market - End-Use Snapshot
- 4.2.Tacrolimus Market Dynamics
- 4.2.1.Drivers and Opportunities
- 4.2.1.1.Increasing research and development activities drive the tacrolimus market growth
- 4.2.1.2.The increasing prevalence of autoimmune diseases facilitating the growth of the market
- 4.2.2.Restraints and Challenges
- 4.2.2.1.Side effects and the availability of the alternative treatments hampering on the tacrolimus market growth
- 4.2.1.Drivers and Opportunities
- 4.3.Porter's Five Forces Analysis
- 4.3.1.Bargaining Power of Suppliers (Moderate)
- 4.3.2.Threats of New Entrants: (Low)
- 4.3.3.Bargaining Power of Buyers (Moderate)
- 4.3.4.Threat of Substitute (Moderate)
- 4.3.5.Rivalry among existing firms (High)
- 4.4.PESTEL Analysis
- 4.5.Tacrolimus Market End-Use Trends
- 4.6.Value Chain Analysis
- 4.7.COVID-19 Impact Analysis
5.Global Tacrolimus Market, by Product Type
- 5.1.Key Findings
- 5.2.Introduction
- 5.2.1.Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 5.3.Injections
- 5.3.1.Global Tacrolimus Market, by Injections, by Region, 2019-2032 (USD Billion)
- 5.4.Tablets and Capsules
- 5.4.1.Global Tacrolimus Market, by Tablets and Capsules, by Region, 2019-2032 (USD Billion)
- 5.5.Others
- 5.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)
6.Global Tacrolimus Market, by Application
- 6.1.Key Findings
- 6.2.Introduction
- 6.2.1.Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 6.3.Dermatitis
- 6.3.1.Global Tacrolimus Market, by Dermatitis, by Region, 2019-2032 (USD Billion)
- 6.4.Immunosuppression
- 6.4.1.Global Tacrolimus Market, by Immunosuppression, by Region, 2019-2032 (USD Billion)
- 6.5.Others
- 6.5.1.Global Tacrolimus Market, by Others, by Region, 2019-2032 (USD Billion)
7.Global Tacrolimus Market, by End-Use
- 7.1.Key Findings
- 7.2.Introduction
- 7.2.1.Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 7.3.Clinics
- 7.3.1.Global Tacrolimus Market, by Clinics, By Region, 2019-2032 (USD Billion)
- 7.4.Hospitals
- 7.4.1.Global Tacrolimus Market, by Hospitals, By Region, 2019-2032 (USD Billion)
- 7.5.Others
- 7.5.1.Global Tacrolimus Market, by Others, By Region, 2019-2032 (USD Billion)
8.Global Tacrolimus Market, by Geography
- 8.1.Key findings
- 8.2.Introduction
- 8.2.1.Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3.Tacrolimus Market - North America
- 8.3.1.North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.3.2.North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.3.North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.3.4.Tacrolimus Market - U.S.
- 8.3.4.1.U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.3.4.2.U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.4.3.U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.3.5.Tacrolimus Market - Canada
- 8.3.5.1.Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.3.5.2.Canada.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.3.5.3.Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.Tacrolimus Market - Europe
- 8.4.1.Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.2.Europe.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.3.Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.4.Tacrolimus Market - UK
- 8.4.4.1.UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.4.2.UK.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.4.3.UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.5.Tacrolimus Market - France
- 8.4.5.1.France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.5.2.France.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.5.3.France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.6.Tacrolimus Market - Germany
- 8.4.6.1.Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.6.2.Germany.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.6.3.Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.7.Tacrolimus Market - Italy
- 8.4.7.1.Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.7.2.Italy.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.7.3.Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.8.Tacrolimus Market - Spain
- 8.4.8.1.Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.8.2.Spain.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.8.3.Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.9.Tacrolimus Market - Netherlands
- 8.4.9.1.Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.9.2.Netherlands.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.9.3.Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.4.10.Tacrolimus Market - Russia
- 8.4.10.1.Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.4.10.2.Russia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.4.10.3.Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.Tacrolimus Market - Asia Pacific
- 8.5.1.Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.2.Asia Pacific.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.3.Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.4.Tacrolimus Market - China
- 8.5.4.1.China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.4.2.China.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.4.3.China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.5.Tacrolimus Market - India
- 8.5.5.1.India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.5.2.India.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.5.3.India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.6.Tacrolimus Market - Malaysia
- 8.5.6.1.Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.6.2.Malaysia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.6.3.Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.7.Tacrolimus Market - Japan
- 8.5.7.1.Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.7.2.Japan.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.7.3.Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.8.Tacrolimus Market - Indonesia
- 8.5.8.1.Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.8.2.Indonesia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.8.3.Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.5.9.Tacrolimus Market - South Korea
- 8.5.9.1.South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.5.9.2.South Korea.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.5.9.3.South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.6.Tacrolimus Market - Middle East & Africa
- 8.6.1.Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.2.Middle East & Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.3.Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.6.4.Tacrolimus Market - Saudi Arabia
- 8.6.4.1.Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.4.2.Saudi Arabia.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.4.3.Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.6.5.Tacrolimus Market - UAE
- 8.6.5.1.UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.5.2.UAE.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.5.3.UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.6.6.Tacrolimus Market - Israel
- 8.6.6.1.Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.6.2.Israel.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.6.3.Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.6.7.Tacrolimus Market - South Africa
- 8.6.7.1.South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.6.7.2.South Africa.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.6.7.3.South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.7.Tacrolimus Market - Latin America
- 8.7.1.Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.2.Latin America.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.3.Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.7.4.Tacrolimus Market - Mexico
- 8.7.4.1.Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.4.2.Mexico.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.4.3.Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.7.5.Tacrolimus Market - Brazil
- 8.7.5.1.Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.5.2.Brazil.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.5.3.Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- 8.7.6.Tacrolimus Market - Argentina
- 8.7.6.1.Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- 8.7.6.2.Argentina.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- 8.7.6.3.Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
9.Competitive Landscape
- 9.1.Expansion and Acquisition Analysis
- 9.1.1.Expansion
- 9.1.2.Acquisitions
- 9.2.Partnerships/Collaborations/Agreements/Exhibitions
10.Company Profiles
- 10.1.Astellas Pharma Inc
- 10.1.1.Company Overview
- 10.1.2.Financial Performance
- 10.1.3.Product Benchmarking
- 10.1.4.Recent Development
- 10.2.Biocon Ltd.
- 10.2.1.Company Overview
- 10.2.2.Financial Performance
- 10.2.3.Product Benchmarking
- 10.2.4.Recent Development
- 10.3.Dr. Reddy's Laboratories Ltd.
- 10.3.1.Company Overview
- 10.3.2.Financial Performance
- 10.3.3.Product Benchmarking
- 10.3.4.Recent Development
- 10.4.Glenmark Pharmaceuticals Inc
- 10.4.1.Company Overview
- 10.4.2.Financial Performance
- 10.4.3.Product Benchmarking
- 10.4.4.Recent Development
- 10.5.GlaxoSmithKline plc
- 10.5.1.Company Overview
- 10.5.2.Financial Performance
- 10.5.3.Product Benchmarking
- 10.5.4.Recent Development
- 10.6.LEO Pharma A/S
- 10.6.1.Company Overview
- 10.6.2.Financial Performance
- 10.6.3.Product Benchmarking
- 10.6.4.Recent Development
- 10.7.Novartis AG
- 10.7.1.Company Overview
- 10.7.2.Financial Performance
- 10.7.3.Product Benchmarking
- 10.7.4.Recent Development
- 10.8.Lupin Pharmaceuticals Inc.
- 10.8.1.Company Overview
- 10.8.2.Financial Performance
- 10.8.3.Product Benchmarking
- 10.8.4.Recent Development
- 10.9.Panacea Biotec
- 10.9.1.Company Overview
- 10.9.2.Financial Performance
- 10.9.3.Product Benchmarking
- 10.9.4.Recent Development
- 10.10.Pfizer Inc
- 10.10.1.Company Overview
- 10.10.2.Financial Performance
- 10.10.3.Product Benchmarking
- 10.10.4.Recent Development
List of Tables
- Table 1 Global Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 2 Global Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 3 Global Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 4 Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 6 North America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 7 North America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 8 U.S.: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 9 U.S.: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 10 U.S.: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 11 Canada: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 12 Canada: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 13 Canada: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 14 Europe: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 15 Europe: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 16 Europe: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 17 UK: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 18 UK: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 19 UK: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 20 France: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 21 France: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 22 France: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 23 Germany: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 24 Germany: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 25 Germany: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 26 Italy: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 27 Italy: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 28 Italy: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 29 Spain: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 30 Spain: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 31 Spain: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 32 Netherlands: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 33 Netherlands: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 34 Netherlands: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 35 Russia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 36 Russia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 37 Russia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 41 China: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 42 China: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 43 China: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 44 India: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 45 India: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 46 India: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 47 Malaysia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 48 Malaysia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 49 Malaysia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 50 Japan: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 51 Japan: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 52 Japan: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 53 Indonesia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 54 Indonesia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 55 Indonesia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 56 South Korea: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 57 South Korea: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 58 South Korea: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 65 UAE: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 66 UAE: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 67 UAE: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 68 Israel: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 69 Israel: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 70 Israel: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 71 South Africa: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 72 South Africa: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 73 South Africa: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 74 Latin America: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 75 Latin America: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 76 Latin America: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 77 Mexico: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 78 Mexico: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 79 Mexico: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 80 Brazil: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 81 Brazil: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 82 Brazil: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
- Table 83 Argentina: Tacrolimus Market, by Product Type, 2019-2032 (USD Billion)
- Table 84 Argentina: Tacrolimus Market, by Application, 2019-2032 (USD Billion)
- Table 85 Argentina: Tacrolimus Market, by End-Use, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Tacrolimus Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Application
- Figure 7. Global Tacrolimus Market, by Application, 2022 & 2032 (USD Billion)
- Figure 8. Market by Product Type
- Figure 9. Global Tacrolimus Market, by Product Type, 2022 & 2032 (USD Billion)
- Figure 10. Market by End-Use
- Figure 11. Global Tacrolimus Market, by End-Use, 2022 & 2032 (USD Billion)
- Figure 12. Tacrolimus Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Tacrolimus Market
